The DEA’s marijuana mistake

The DEA and the National Institute for Drug Abuse block serious research on medical uses of marijuana, creating a ridiculous circle of denials.

A pro-marijuana group lost its legal battle this week when a federal appellate court ruled that marijuana would remain a Schedule I drug, defined as having no accepted medical value and a high potential for abuse. (Alan Berner / Seattle Times / MCT / January 24, 2013)

For a muscular agency that combats vicious drug criminals, the U.S. Drug Enforcement Administration acts like a terrified and obstinate toddler when it comes to basic science. For years, the DEA and the National Institute forDrug Abuse have made it all but impossible to develop a robust body of research on the medical uses of marijuana.

A pro-marijuana group lost its legal battle this week when a federal appellate court ruled that marijuana would remain a Schedule I drug, defined as having no accepted medical value and a high potential for abuse. The court deferred to the judgment of federal authorities, quoting the DEA’s statement that “the effectiveness of a drug must be established in well-controlled, well-designed, well-conducted and well-documented scientific studies…. To date, such studies have not been performed. Read the full story>> Latimes